0001578563-24-000079.txt : 20240215 0001578563-24-000079.hdr.sgml : 20240215 20240215170309 ACCESSION NUMBER: 0001578563-24-000079 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAYER AKTIENGESELLSCHAFT CENTRAL INDEX KEY: 0001144145 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41949 FILM NUMBER: 24644693 BUSINESS ADDRESS: STREET 1: BAYERWERK, GEBAEUDE W11 STREET 2: KAISER-WILHELM-ALLEE CITY: LEVERKUSEN STATE: 2M ZIP: D-51368 BUSINESS PHONE: 492143081933 MAIL ADDRESS: STREET 1: BAYERWERK, GEBAEUDE W11 STREET 2: KAISER-WILHELM-ALLEE CITY: LEVERKUSEN STATE: 2M ZIP: D-51368 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAYER HEALTHCARE LLC CENTRAL INDEX KEY: 0001231517 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41949 FILM NUMBER: 24644696 BUSINESS ADDRESS: STREET 1: 511 BENEDICT AVE. CITY: TARRYTOWN STATE: NY ZIP: 10591-5097 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bayer US Holding LP CENTRAL INDEX KEY: 0001965754 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41949 FILM NUMBER: 24644695 BUSINESS ADDRESS: STREET 1: 100 BAYER BOULEVARD CITY: WHIPPANY STATE: NJ ZIP: 07981 BUSINESS PHONE: (862) 404-3000 MAIL ADDRESS: STREET 1: 100 BAYER BOULEVARD CITY: WHIPPANY STATE: NJ ZIP: 07981 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bayer World Investments B.V. CENTRAL INDEX KEY: 0001820027 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41949 FILM NUMBER: 24644694 BUSINESS ADDRESS: STREET 1: ENERGIEWEG 1 CITY: MIJDRECHT STATE: P7 ZIP: 3641 BUSINESS PHONE: 00 31 297 280 666 MAIL ADDRESS: STREET 1: ENERGIEWEG 1 CITY: MIJDRECHT STATE: P7 ZIP: 3641 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Metagenomi, Inc. CENTRAL INDEX KEY: 0001785279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813909017 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET STREET 2: 7TH FLOOR CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-4880 MAIL ADDRESS: STREET 1: 5959 HORTON STREET STREET 2: 7TH FLOOR CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Metagenomi Technologies, LLC DATE OF NAME CHANGE: 20190812 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2024-02-08 0 0001785279 Metagenomi, Inc. MGX 0001231517 BAYER HEALTHCARE LLC 100 BAYER BOULEVARD WHIPPANY NJ 07981 0 0 1 0 0001965754 Bayer US Holding LP 100 BAYER BOULEVARD WHIPPANY NJ 07981 0 0 1 0 0001820027 Bayer World Investments B.V. SIRIUSDREEF 36 HOOFDDORP P7 2132WT NETHERLANDS 0 0 1 0 0001144145 BAYER AKTIENGESELLSCHAFT BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE 1 LEVERKUSEN 2M 51373 GERMANY 0 0 1 0 Series A-1 Convertible Preferred Stock Common Stock 1770888 D Series A-4 Convertible Preferred Stock Common Stock 1180592 D Series B Convertible Preferred Stock Common Stock 589662 D Series B-1 Convertible Preferred Stock Common Stock 509855 D Each share of Series A-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Each share of Series A-1 Convertible Preferred Stock has no expiration date. The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC. Each share of Series A-4 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series A-4 Convertible Preferred Stock has no expiration date. Each share of Series B Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date. Each share of Series B-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B-1 Convertible Preferred Stock has no expiration date. Bayer HealthCare LLC, By:/s/ Priyal Patel, Name: Priyal Patel, Title: Treasurer 2024-02-15 Bayer US Holding LP, By: /s/ Priyal Patel, Name: Priyal Patel, Title: Treasurer 2024-02-15 Bayer World Investments B.V., By: /s/ Kati Schnuerer, Name: Kati Schunerer, Title: Managing Director 2024-02-15 Bayer Aktiengesellschaft, By: /s/ Thomas Hoffman, Name: Thomas Hoffman, Title: Head of Treasury 2024-02-15